As stromal MyofKO impaired tumor desmoplasia in mice, we aimed to assess the effect of myoferlin targeting in a pharmacological model, thus enabling an initial tumor establishment prior to treatment administration (Fig. 7G). Here, MYOF is linked to neoplasm.